Literature DB >> 26097530

An enterovirus 71 strain causes skeletal muscle damage in infected mice.

Peixin Lin1, Lulu Gao1, Yeen Huang1, Qing Chen2, Hong Shen1.   

Abstract

OBJECTIVE: To study the target organs for enterovirus 71 (EV71) in infected suckling mice.
METHODS: 5-day-old BALB/c suckling mice were infected with an EV71 strain. Tissues of the infected mice were processed for histopathological examination, including immunohistochemistry, in situ hybridization, ultrastructural observation.
RESULTS: Some mice developed limb paralysis, trouble walking and loss of balance. Results of the histopathological study showed that a large amount of EV71 existed in the skeletal muscle tissues, accounting for the damage of the skeletal muscles.
CONCLUSION: The EV71 clinical isolate used in this study presented evident myotropism. Skeletal muscles are important target organs for EV71 in the infected suckling mice. To clarify the relationship between EV71 infection and muscle diseases may contribute to a better understanding of the pathogenesis of EV71.

Entities:  

Keywords:  BALB/c mice; Enterovirus 71; histopathological examination; mitochondrial injury; myotropism; skeletal muscle damage

Mesh:

Year:  2015        PMID: 26097530      PMCID: PMC4466917     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  Retrograde axonal transport: a major transmission route of enterovirus 71 in mice.

Authors:  Che-Szu Chen; Yi-Chuan Yao; Shin-Chao Lin; Yi-Ping Lee; Ya-Fang Wang; Jen-Ren Wang; Ching-Chuan Liu; Huan-Yao Lei; Chun-Keung Yu
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

Review 2.  An overview of the evolution of enterovirus 71 and its clinical and public health significance.

Authors:  Peter C McMinn
Journal:  FEMS Microbiol Rev       Date:  2002-03       Impact factor: 16.408

3.  Neurologic complications in children with enterovirus 71 infection.

Authors:  C C Huang; C C Liu; Y C Chang; C Y Chen; S T Wang; T F Yeh
Journal:  N Engl J Med       Date:  1999-09-23       Impact factor: 91.245

4.  Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria.

Authors:  M Chumakov; M Voroshilova; L Shindarov; I Lavrova; L Gracheva; G Koroleva; S Vasilenko; I Brodvarova; M Nikolova; S Gyurova; M Gacheva; G Mitov; N Ninov; E Tsylka; I Robinson; M Frolova; V Bashkirtsev; L Martiyanova; V Rodin
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

5.  A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection.

Authors:  Ya-Fang Wang; Chun-Ting Chou; Huan-Yao Lei; Ching-Chuan Liu; Shih-Min Wang; Jing-Jou Yan; Ih-Jen Su; Jen-Reng Wang; Trai-Ming Yeh; Shun-Hua Chen; Chun-Keung Yu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis.

Authors:  Kien Chai Ong; Munisamy Badmanathan; Shamala Devi; Kum Loong Leong; Mary Jane Cardosa; Kum Thong Wong
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

Review 7.  Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease.

Authors:  Maik Hüttemann; Icksoo Lee; Alena Pecinova; Petr Pecina; Karin Przyklenk; Jeffrey W Doan
Journal:  J Bioenerg Biomembr       Date:  2008-10-09       Impact factor: 2.945

8.  Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000).

Authors:  Sunita Singh; Chit Laa Poh; Vincent Tak Kwong Chow
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

9.  Experimental myocarditis induced by two different coxsackievirus B3 variants: aspects of pathogenesis and comparison of diagnostic methods.

Authors:  A Arola; H Kalimo; O Ruuskanen; T Hyypiä
Journal:  J Med Virol       Date:  1995-11       Impact factor: 2.327

10.  A murine oral enterovirus 71 infection model with central nervous system involvement.

Authors:  Yi-Chun Chen; Chun-Keung Yu; Ya-Fang Wang; Ching-Chuan Liu; Ih-Jen Su; Huan-Yao Lei
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

View more
  6 in total

1.  A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71.

Authors:  Cheng-Hung Yang; Chung-Tiang Liang; Si-Tse Jiang; Kuan-Hsing Chen; Chun-Chiao Yang; Mei-Ling Cheng; Hung-Yao Ho
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

2.  Ribavirin as a curative and prophylactic agent against foot and mouth disease virus infection in C57BL/6 suckling and adult mice model.

Authors:  Patel Nikunjkumar; Ramasamy Periyasamy Tamil Selvan; Veerakyathappa Bhanuprakash
Journal:  Virusdisease       Date:  2021-10-20

Review 3.  Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection.

Authors:  Jingjun Xing; Ke Wang; Geng Wang; Na Li; Yanru Zhang
Journal:  Arch Virol       Date:  2022-09-29       Impact factor: 2.685

4.  Isochlorogenic acid C prevents enterovirus 71 infection via modulating redox homeostasis of glutathione.

Authors:  Zeyu Cao; Yue Ding; Liang Cao; Gang Ding; Zhenzhong Wang; Wei Xiao
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

5.  Analysis of miRNAs Involved in Mouse Brain Damage upon Enterovirus 71 Infection.

Authors:  Xiaoxia Yang; Jing Xie; Leili Jia; Nan Liu; Yuan Liang; Fuli Wu; Beibei Liang; Yongrui Li; Jinyan Wang; Chunyu Sheng; Hao Li; Hongbo Liu; Qiuxia Ma; Chaojie Yang; Xinying Du; Shaofu Qiu; Hongbin Song
Journal:  Front Cell Infect Microbiol       Date:  2017-04-19       Impact factor: 5.293

6.  Involvement of inducible nitric oxide synthase and mitochondrial dysfunction in the pathogenesis of enterovirus 71 infection.

Authors:  Dejian Dang; Chao Zhang; Rongguang Zhang; Weidong Wu; Shuaiyin Chen; Jingchao Ren; Peng Zhang; Guangyuan Zhou; Demin Feng; Tiantian Sun; Ying Li; Qiaoli Liu; Mengchen Li; Yuanlin Xi; Yuefei Jin; Guangcai Duan
Journal:  Oncotarget       Date:  2017-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.